The effects of traditional medicine Product on oligomenorrhea

Comparison of traditional medicine product and medroxyprogesterone tablet on oligo/Amenorrhea in women of reproductive age

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015063022987N1

Enrollment

Registered

2017-11-19

Start date

2017-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligomenorrhea. Secondary oligomenorrhoea

Interventions

Intervention 1: Medroxyprogesterone tablets 5 mg, twice a day, for 10 days and in subsequent cycles from 16 to 25 menstruation in the same way. Intervention 2: Combined herbal tea based on fennel, 2

Treatment - Drugs

Medroxyprogesterone tablets 5 mg, twice a day, for 10 days and in subsequent cycles from 16 to 25 menstruation in the same way

Combined herbal tea based on fennel, 2 times a day, each time a t-bag, for 3 menstrual periods. Duration of use is two weeks in each course that begins a week after purity in period 2 and 3.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with oligo/Amenorrhea; Aged between 18 to 40 years; Negative pregnancy test; Patient satisfaction . Exclusion criteria: Pregnancy or breast-feeding; Abnormal prolactin levels ;Abnormal thyroid function tests ; FSH> 20 IU / L ;History of organic diseases or gynecological neoplasia;History of chronic renal or hepatic diseases; Severe drug allergy or a history of severe reactions toward unusual plants; Use of Ciprofloxacin, dopamine agonists and antagonists, anti androgens and estrogens; History of any type of chemical hormonal products in 1 month ago; Patients who need other interventions and surgery; Patients with a personal decision to exit from the study

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Start of bleeding. Timepoint: Before intervention and 1, 2 & 3 months later. Method of measurement: Question.;FSH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;LH. Timepoint: Beginning & end of study. Method of measurement: ELISA.;Total testosterone. Timepoint: Beginning & end of study. Method of measurement: ELISA.	—

Secondary

Measure	Time frame
Side effects. Timepoint: During the study. Method of measurement: Question.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnoush Falahat

Mashhad University of Medical Sciences

Falahatf901@mums.ac.ir+98 51 3855 2189

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026